Update on medical treatment of female stress urinary incontinence

Gynécologie, obstétrique & fertilité
C YazbeckP Madelenat

Abstract

A reasonable assumption is that incontinence would be relieved by increasing urethral resistance through stimulating alpha-adrenergic receptors in urethral smooth muscle. A review of available medical treatment of stress urinary incontinence is done. Alpha-receptor agonists are not in common use because of systemic side-effects. Estrogens do not seem to have beneficial effect on stress urinary incontinence. Currently, new molecules such as duloxetine, are uptake inhibitor of serotonin and noradrenaline could provide a noninvasive therapy for patients with urinary incontinence. Further studies to identify clinical applications are required.

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

BJOG : an International Journal of Obstetrics and Gynaecology
M OelkeM C Michel
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
Maya Basu, Jonathan Duckett
American Journal of Obstetrics and Gynecology
Peggy A NortonDuloxetine Urinary Incontinence Study Group
© 2022 Meta ULC. All rights reserved